NCT06610500View on ClinicalTrials.gov

Clozapine Hematological Monitoring Regulatory Compliance Assessment in Psychiatry

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

May 16, 2023

Primary Completion Date

September 12, 2023

Study Completion Date

September 12, 2023

Conditions
SchizophreniaAgranulocytosis
Interventions
OTHER

Questionnaires

Questionnaires investigating the prescription and dispensing of clozapine.

Trial Locations (1)

42000

CHU Saint Etienne, Saint-Etienne

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Saint Etienne

OTHER

NCT06610500 - Clozapine Hematological Monitoring Regulatory Compliance Assessment in Psychiatry | Biotech Hunter | Biotech Hunter